It is also true, however, as in the case of PRRT2 paroxysmal kinesigenic dyskinesias, that having positive genetics allows us to go more safely towards a therapy such as carbamazepine or other sodium blockers, to strengthen the clinical suspicion of the referring physician. This evidence concerns the gene PRRT2 and episodic kinesigenic dyskinesia 1.